| Date | Title | Description |
| 18.11.2024 | Quanta Dialysis Technologies Closes Over $60M Series E Funding | Quanta Dialysis Technologies, a Warwick, UK-based company dedicated to transforming kidney care through its Quanta™ Dialysis System, raised over $60M in Series E funding.
The round was led by Novo Holdings, Glenview Capital and b2venture, w... |
| 30.09.2023 | New expanded indication will increase home hemodialysis device options available to patients with end-stage kidney disease. | Beverly, Massachusetts, USA. 19 September 2023. Seroba’s portfolio company, Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced that it has submitted a 510(k) premarke... |
| 19.08.2023 | Quanta™ Announces Enrollment Completion in Home Run Study. | Beverly, Massachusetts, U.S.A. 17 August 2023. Seroba’s portfolio company, Quanta Dialysis Technologies®, today announced that it has completed enrollment of its Home Run study for at-home hemodialysis. The Home Run study is a prospective, ... |
| 05.08.2023 | Quanta™ Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies. | Beverly, Mass., USA. 3 August, 2023. Quanta Dialysis System becomes first-in-class to perform three standard-of-care dialysis modalities in one device.
Quanta Dialysis Technologies®, a medical technology company committed to making kidney ... |
| 28.09.2022 | Quanta Appoints Alejandro Galindo as Chief Executive Officer | Quanta appoints Alejandro Galindo as its next CEO
Unanimous Endorsement of MannKind Executive Follows Extensive Search BEVERLY, MASSACHUSETTS, USA, September 28, 2022 /EINPresswire.com/ -- Quanta Dialysis Technologies® Ltd (“Quanta” or the ... |
| 28.10.2021 | Photography exhibition highlights lives of people with Chronic Kidney Disease | Photography exhibition highlights lives of people with Chronic Kidney Disease
Quanta sponsors private viewing of Survivors: Life Unfiltered to raise awareness of chronic kidney disease
ALCESTER, England, 28 October 2021: Quanta Dialysis Tec... |
| 25.06.2021 | This British medtech startup raises $245M to improve the lives of dialysis patients; here’s how | Dialysis is a life-sustaining treatment for patients with End-Stage Renal Disease (ESRD). Globally, the dialysis population is growing, particularly in low-income and middle-income countries.
“A substantial number of people lack access to k... |
| 25.06.2021 | Quanta Raises $245M In Series D Funding | Quanta Dialysis Technologies Ltd, an Alcester, England, and Beverly, MA-based medical technology company focusing dialysis care, raised $245m in Series D funding.
The round was led by Glenview Capital and co-led by Novo Holdings, with parti... |
| 23.06.2021 | Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System | Quanta announced that it has raised $245 million in an oversubscribed and upsized Series D round, the largest private funding round for a dialysis device company in history. |
| 23.06.2021 | Former Department of Transportation Secretary, Elaine Chao, returns to the private sector | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content Why a company’s ethics are as important as its products From Moodys
After a tumultuo... |
| 23.06.2021 | Former Department of Transportation Secretary, Elaine Chao, returns to the private sector | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
After a tumultuous 2020 election that culminated in an insurrection at the U.S. Capitol, many won... |
| 12.02.2021 | QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer | QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer
Alcester, Warwickshire, UK, 12 February 2021: QUANTA Dialysis Technologies Ltd (“QUANTA” or the “Company”), a British medical technology pioneer developing innovative dialysis p... |
| 12.02.2021 | QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer | QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer
Alcester, Warwickshire, UK, 12 February 2021: QUANTA Dialysis Technologies Ltd (“QUANTA” or the “Company”), a British medical technology pioneer developing innovative dialysis pro... |
| 08.01.2021 | Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch | Quanta announced that it has received 510(k) clearance from the US Food and Drug Administration (“FDA”) to market its small and simple, high performance hemodialysis system SC+. |
| 30.07.2019 | Daily funding roundup - July 30th, 2019 | DataGrail raised $5M; Connected2Fiber landed $5.3M; Socio secured $6M; Physna closed $6.9M
DataGrail: DataGrail is a purpose-built privacy management platform that ensures sustained compliance with the GDPR, CCPA, and more. DataGrail has ra... |
| 29.07.2019 | Quanta Raises $48M in Series C Funding | Quanta Dialysis Technologies Ltd, an Alcester, Warwickshire, UK-based medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, raised £38m ($48m) in a first closing of its Serie... |
| 29.07.2019 | Quanta Dialysis Technologies raises $48m | Quanta Dialysis Technologies (Alcester, U.K.) said today that it has closed on a £38 million ($48 million) Series C funding round.
The money will support the British commercial launch of the company’s SC+ personal hemodialysis system as wel... |
| 29.07.2019 | British medtech company Quanta raises $48 million in Series C funding as it gears up for commercial launch | UK-based medical technology company Quanta, which develops compact but advanced haemodialysis systems – under the brand ‘SC+’ – for use in the home and in clinics, has secured $48 million in Series C funding.
The financing round was led by ... |
| - | Quanta provides compact dialysis systems to NHS to support increased need caused by COVID-19 pandemic | Alcester, Warwickshire, UK. 01 June 2020. Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology innovation company, today announced that it has been proudly supporting the ongoing Nat... |
| - | John S. Lipman Appointed as Quanta’s President, North America. | Alcester, Warwickshire, UK. 24 November 2020. Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology company developing innovative dialysis products and services, has announced the app... |
| - | Quanta SC+ confirmed as safe and easy to use. | Alcester, Warwickshire, UK. 15 April 2019. Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a pioneering medical technology company developing a personal haemodialysis system (SC+) for patient use in... |
| - | Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System | Alcester, England & Beverly, Mass., USA. June 23, 2021. Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology leader delivering on its vision for more flexible and accessible dialysis care, announced today t... |
| - | Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch | Alcester, Warwickshire, UK. 8 January 2021. Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or “the Company”), a medical technology pioneer developing innovative dialysis products and services for the global market, t... |
| - | Quanta Announces Collaboration with B. Braun Avitum UK Ltd | Alcester, Warwickshire, UK. 13 January 2020. Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology company that has developed a personal haemodialysis system called SC+, today announc... |
| - | Quanta Appoints New Chief Medical Officer | Alcester, UK, 4 Jan 2019: Seroba portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions for clinic and home settings, today announced the Compan... |
| - | Quanta Wins Industrial Product Design 2018. | Alcester, UK. 1 October 2018. Quanta Dialysis Technologies Ltd (“Quanta”), a medical device company pioneering innovative haemodialysis products for dialysis patients, is pleased to announce that it has won the “Industrial Product Design of... |
| - | Quanta Raises $48 million in Series C Funding Round. | Alcester, Warwickshire, UK. 29 July 2019. Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical technology company developing a personal haemodialysis system (SC+) for patient use in the... |
| - | Quanta Successfully Completes Pilot Treatments in France. | Alcester, UK. 25 April 2018. Seroba’s investee company Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions, has announced that it has successfully completed a c... |
